Skip to content
  • Global Key Solutions is now KeyPedia →
  • Independent Study of FDA Correspondence Finds Earliest CDER Warning Letter Citing AI Use →
  • KeyPedia Launches openFDA MCP Connector With an "Elsa for Industry" Approach →
  • KeyPedia Listed in TPRA’s TPRM Tools List →
  • Global Key Solutions is now KeyPedia →
  • Independent Study of FDA Correspondence Finds Earliest CDER Warning Letter Citing AI Use →
  • KeyPedia Launches openFDA MCP Connector With an "Elsa for Industry" Approach →
  • KeyPedia Listed in TPRA’s TPRM Tools List →
KeyPediaKeyPedia
  • Company
  • Platform
  • Media
  • KeyPedia Lite
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Aurobindo Pharma USA Inc
FDA Inspection•Aurobindo Pharma USA Inc•May 15, 2024

Aurobindo Pharma USA Inc – FDA Inspection, May 15, 2024

Record Details

This FDA Inspection record concerns Aurobindo Pharma USA Inc, with an inspection on May 15, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Aurobindo Pharma USA Inc
Inspection Date
May 15, 2024
Product Type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Samir C. Gala (FDA Associated Person)

ID · 653906f9-7952-4bff-9baa-c6b093dcc401

Inspection Facts

Official Action Indicated (OAI)

Significant objectionable conditions were found and regulatory or administrative action is recommended.

Inspection number
1238442
FDA center
Human Drugs
Project area
Drug Quality Assurance

FDA Citations

2
  1. FDCA 582(b)(4)Systems in place to comply with verification requirements
  2. FDCA 582(b)(4)(B)(ii)(I)Notify FDA and immediate trading partners of illegitimate product

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Aurobindo Pharma USA Inc

4
DateClassificationOfficeProject area
June 4, 2026Not classifiedNew Jersey District Office
December 12, 2014NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
May 30, 2012NAICenter for Drug Evaluation and ResearchBioresearch Monitoring
July 29, 2011VAICenter for Drug Evaluation and ResearchBioresearch Monitoring

Other documents for Aurobindo Pharma USA Inc

4
Document
FDA Inspection 1316082 · June 4, 2026 
FDA Inspection 908515 · December 12, 2014 
FDA Inspection 783745 · May 30, 2012 
FDA Inspection 736360 · July 29, 2011 
View Company ProfileHave an account? Sign in to open in Dashboard

Or discuss it with

What you get

  1. A document

    One file.

    • One FDA document, such as a Form 483
    • Yours for life in your Library
    • Each has its own price
    here
  2. The profile

    All the documents, plus intelligence about the company.

    • Every Aurobindo Pharma USA Inc document on file
    • The KRA score, which a single document does not include
    • Observations and inspection history
  3. Access

    This, for every company on KeyPedia.

    • Combine profiles in one search
    • Search across any modality: products, industry types, drugs, devices and recalls
    • Track everything as it changes
    • Other agencies too, such as EMA, Health Canada and UK MHRA
    Browse free in KeyPedia Lite
KeyPedia
The intelligence layer for life sciences
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
Quick Links
HomePlatformUse CasesHardwarePricingResearchOur TechnologyFAQMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPrograms & Partnerships
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.